Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.
about
Genetic subdivisions within Trypanosoma cruzi (Discrete Typing Units) and their relevance for molecular epidemiology and experimental evolutionRevisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineageFexinidazole: a potential new drug candidate for Chagas diseaseTrypanosoma cruzi I and IV stocks from Brazilian Amazon are divergent in terms of biological and medical properties in miceBenznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatmentsBenznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas DiseaseItraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.Drug strategies targeting CYP51 in neglected tropical diseasesExperimental evidence of biological interactions among different isolates of Trypanosoma cruzi from the Chaco RegionExperimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IVConcomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruziImpact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruziDifferential pattern of infection of sylvatic nymphs and domiciliary adults of Triatoma infestans with Trypanosoma cruzi genotypes in ChileCynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas diseasePerformance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection.Acute Chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia.Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations.Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi.Potential new clinical therapies for Chagas disease.Therapeutical approaches under investigation for treatment of Chagas disease.The Role of Heme and Reactive Oxygen Species in Proliferation and Survival of Trypanosoma cruzi.Transcriptome and Functional Genomics Reveal the Participation of Adenine Phosphoribosyltransferase in Trypanosoma cruzi Resistance to Benznidazole.Biological factors that impinge on Chagas disease drug development.Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi.Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.Trypanosoma cruzi I genotype among isolates from patients with chronic Chagas disease followed at the Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ, Brazil).Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole.Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.Genotyping of Trypanosoma cruzi sublineage in human samples from a North-East Argentina area by hybridization with DNA probes and specific polymerase chain reaction (PCR).Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection.Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole.In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
P2860
Q24793457-20A74A4B-9C55-45C5-A532-44AB570794F5Q26859040-BC636CD4-2821-4AB1-9588-69EABD964471Q28481727-3607BD0C-619B-47F5-936C-5D0215816EA4Q28484826-9520467B-6998-496B-AAC0-5FD64DB305CFQ28486306-F6E9A8D2-A744-453F-A501-D6588299EBAFQ28535357-4D86326D-76F0-48A8-A2FF-DFC44D34BF46Q28548342-0C0E604E-84D9-4139-A7E2-DCCECE2A5841Q33227507-4D38529F-772D-495D-A0D6-64C3E1CFAF68Q34622554-D348E323-4B36-4181-AC3A-C9853C4AF098Q35195691-893582A3-B3D1-4AC3-B375-0E1350363DF1Q35210866-F2E83542-8133-49AC-8009-EA408A1ADA0BQ35692509-C87D3E9D-F5EF-4E9A-A921-17B993DAC9B8Q36075925-4713610B-F823-4977-ADD7-F321DEBC07F0Q36094866-3E27AC2D-89C3-4193-AD6A-E9A5F91143D1Q36213271-7639A46F-901F-4986-A9D5-CFA588B722D2Q36287327-DCC92C30-6E3B-4A9E-A51A-8A056A0D20A1Q36319617-26841D93-D763-4239-8C4F-D0030222993CQ36324922-E3E77BE9-EBDC-4D58-938F-28D2FC490CBFQ36446085-37CE3B4F-0527-416B-AC20-A96624825F0DQ37124216-8BF76A35-F2E6-4ABA-AA90-B3011B423938Q37597052-276281DE-064A-472C-B76C-BB6EE383D4D2Q37717875-09B62099-9F56-4AB7-B530-265881F72172Q37835034-AEF3B007-D7C9-4193-AFD4-C7F37E80B53FQ38203330-4C65ECE5-F4C3-4C7D-9230-2F5A579D8FE0Q38214136-95521173-F01F-40BA-A762-4DD2AD3C0933Q38684227-432A7650-0E92-42D6-8D15-7D97E93AD03BQ38918864-4120CD19-7EA7-4F35-A39F-72F137FD1A68Q39010376-BCEBC883-79EC-45DA-B362-36E67010D026Q39075901-526FF0A2-427A-439A-8268-902A0EC26D06Q39701339-7E7F78DE-B0EA-45B6-B480-C09CF0E61F3BQ40284487-51B4AA92-2810-483E-9D22-02A2EF60CF7FQ40290159-D73B6443-5383-48F1-AF46-C9EEEC95E65AQ41856398-D71F729B-ED7A-4E09-84FB-4E6CBA718091Q42108785-AE841FCA-282D-43C3-9C56-E51A1D0BECFEQ42789311-60964681-F272-43E2-987F-791C58985616Q42941204-3619B920-022F-4B41-80D8-43CB26AD6C30Q43288949-63CC4B19-74F3-4D84-A1E7-2E22FB58E967Q43563878-A232F8F8-21C0-4576-BCE9-A117F8D5A3DCQ44632564-7DA0A477-47D9-48B6-8839-094DDF6E4868Q46430988-6EA387C5-AE7B-4406-89B0-510E3DA3CCD4
P2860
Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@ast
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@en
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@nl
type
label
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@ast
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@en
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@nl
prefLabel
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@ast
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@en
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@nl
P2093
P2860
P50
P1476
Chemotherapy with benznidazole ...... nosoma cruzi clonal genotypes.
@en
P2093
Cláudia M Carneiro
Maria Terezinha Bahia
Max Jean de Ornelas Toledo
Olindo Assis Martins-Filho
Washington Luis Tafuri
P2860
P304
P356
10.1128/AAC.47.1.223-230.2003
P407
P577
2003-01-01T00:00:00Z